SCHEMBL28358935

SCHEMBL28358935

CS(=O)(=O)c1ccc(Nc2cc(-c3c(F)cccc3F)nnc2C(N)=O)nc1

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 12/20 0.61
▸ JAK2 O60674 11/20 0.61
▸ JAK1 P23458 9/20 0.61
▸ JAK3 P52333 9/20 0.61
▸ SYK P43405 4/20 0.39
▸ PDE4B Q07343 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29552269 0.91 TYK2 (0.51) TYK2JAK2JAK1JAK3
SCHEMBL29922615 0.90 TYK2 (0.50) TYK2JAK2JAK1JAK3
SCHEMBL28358938 0.90 TYK2 (0.50) TYK2JAK2JAK1JAK3
SCHEMBL28883611 0.85 JAK2 (0.59) TYK2JAK2JAK1JAK3
SCHEMBL28359209 0.84 TYK2 (0.67) TYK2JAK2JAK1JAK3SYK
SCHEMBL29552906 0.84 TYK2 (0.67) TYK2JAK2JAK1JAK3SYK
SCHEMBL29552360 0.82 TYK2 (0.65) TYK2JAK2JAK1JAK3SYK
SCHEMBL28359026 0.80 TYK2 (0.60) TYK2JAK2JAK1JAK3SYK
SCHEMBL29552180 0.80 TYK2 (0.60) TYK2JAK2JAK1JAK3SYK
SCHEMBL29552966 0.80 TYK2 (0.50) TYK2JAK2JAK1JAK3SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback